Middle East & Africa Coagulation Market Forecast to 2030
Middle East & Africa Coagulation Market Forecast to 2030 – Regional Analysis – by Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand’s Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), and End User (Clinical Laboratories, Hospitals, and Others)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Development of Point-of-Care (POC) Coagulation Analyzers Fuel Middle East & Africa Coagulation Market
A rapid, reliable assessment of hemostasis is essential for patients suffering from trauma or other bleeding problems. Due to the constraints of sample preparation and analytical process, routine coagulation assays cannot analyze clot formation, and their results can be obtained only after 30-90 minutes. POC devices such as platelet function test, viscoelastic coagulation tests, blood gas analysis, and other coagulometers are available for assessment of hemostasis. A POC measurement tool can be used inside and outside the hospital as a decision-making and management tool. When time is paramount, POC analyzers provide immediate, actionable results in emergency rooms, coronary care units, surgery, and procedure suites. In addition to outpatient clinics and physicians’ offices, these devices can assist in patient management in pharmacies, care centers, and patients’ homes. POC coagulation analyzers offer timely results without compromising diagnostic quality control provided by central labs. In POC testing, it is important to provide fast results, along with accuracy and quality assurance.
In 2021, Siemens Healthineers launched fully automated CN-3000 and CN-6000 systems, which are mid- and high-volume handheld POC coagulation testing devices. The FDA cleared Siemens Healthineers’ Xprecia Stride Coagulation Analyser in 2016, as a POC coagulation analyzer device. The device has demonstrated prothrombin time/international normalized ratio (PT/INR) testing performance equivalence to Roche CoaguChek XS.
Thus, the growing developments in POC coagulation analyzers are expected to boost the coagulation market growth during the forecast period.
Middle East & Africa Coagulation Market Overview
The Middle East & Africa coagulation market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Market growth in this region is mainly ascribed to developments in medical facilities, the increasing prevalence of blood disorders, and the growing incidence of AFib and other cardiovascular diseases.
Saudi Arabia is one of the important Middle Eastern countries with significant scope for the coagulation market. According to the “Assessment of Venous Thromboembolism Awareness in Makkah, Saudi Arabia” study, venous thromboembolism affects ~25,000 people in Saudi Arabia every year. As per the article “Prevalence of venous thromboembolism in patients with acetabular or hip fractures,” published in the Journal of Musculoskeletal Surgery and Research in 2020, the prevalence of hospital-acquired deep vein thrombosis in Saudi Arabia ranges from 10% to 40% in surgical and medical patients. Venous thromboembolism and deep vein thrombosis is a condition where blood clot occurs in the body part such as the deep vein. Thus, the increasing prevalence of blood disorders such as venous thromboembolism, hemophilia, and clotting factor diseases is fueling the growth of the market in Saudi Arabia.
Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Coagulation Market Segmentation
The Middle East & Africa coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.
Based on disease indication, the Middle East & Africa coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand’s disease, and others. The liver disease segment held the largest Middle East & Africa coagulation market share in 2022.
Based on type, the Middle East & Africa coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Middle East & Africa coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.
In terms of offering, the Middle East & Africa coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Middle East & Africa coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.
By technology, the Middle East & Africa coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Middle East & Africa coagulation market share in 2022.
By end user, the Middle East & Africa coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Middle East & Africa coagulation market share in 2022.
Based on country, the Middle East & Africa coagulation market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa coagulation market in 2022.
Siemens Healthineers AG; ImproGen Diagnostik Kimya San & Tic Ltd ?ti; Sysmex Corp; F. Hoffmann-La Roche Ltd; Genrui Biotech Co Ltd; Transasia Bio-Medicals Ltd; and Horiba Ltd are some of the leading companies operating in the Middle East & Africa coagulation market.
Summary Info
Industry: | |
---|---|
Pricing options: | |
Geographical coverage: | |
Year of Publication: |
According to the Research Team’ research, the Middle East & Africa coagulation market was valued at US$ 291.47 million in 2022 and is expected to reach US$ 467.78 million by 2030, registering a CAGR of 6.1% from 2022 to 2030. Rising prevalence of cardiovascular diseases and increasing prevalence of blood disorders are among the critical factors attributed to the Middle East & Africa coagulation market expansion.
According to the Global Hemophilia Care 2020 study, 393,658 bleeding disorders cases have been recognized and documented worldwide over time, including 241,535 hemophilia cases, 87,729 von Willebrand disease cases, and 64,394 other bleeding disorder cases. Therefore, the rising prevalence of blood disorders drives the coagulation market growth.
A coagulation analyzer is a device that measures and evaluates the speed of clot formation or clot coagulation. It provides a fast, simple way to accurately measure blood platelet levels and thrombin and thromboplastin levels. According to the Annual Global Survey 2020 conducted by the World Federation of Hemophilia, around 347,026 people had bleeding disorders, and about 209,614 people were living with hemophilia. This included 165,379 with Hemophilia A, 33,076 with Hemophilia B, 11,159 with Hemophilia type unknown, 84,197 with von Willebrand disease, and 53,215 with other bleeding disorders. Furthermore, individuals from the Middle East can also be affected by sickle cell trait. Over 100 million individuals globally possess the sickle cell trait. Sickle cell disease is one of the most common inherited blood disorders. Thus, the rising prevalence of blood disorders is driving the coagulation market.
On the contrary, high costs associated with coagulation analyzers hampers the growth Middle East & Africa coagulation market.
Based on disease indication, the Middle East & Africa coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von Willebrand’s disease, and others. The liver disease segment held 54.2% share of the Middle East & Africa coagulation market in 2022, amassing US$ 158.02 million. It is projected to garner US$ 250.26 million by 2030 to expand at 5.9% CAGR during 2022–2030.
Based on type, the Middle East & Africa coagulation market is bifurcated into clinical laboratory analyzers and point-of-care testing analyzers. The clinical laboratory analyzers segment held 66.0% share of the Middle East & Africa coagulation market in 2022, amassing US$ 192.46 million. It is projected to garner US$ 294.21 million by 2030 to expand at 5.4% CAGR during 2022–2030. Clinical laboratory analyzers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.
In terms of offering, the Middle East & Africa coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held 65.1% share of the Middle East & Africa coagulation market in 2022, amassing US$ 189.83 million. It is projected to garner US$ 300.93 million by 2030 to expand at 5.9% CAGR during 2022–2030. Diagnosis is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.
By technology, the Middle East & Africa coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held 60.7% share of Middle East & Africa coagulation market in 2022, amassing US$ 176.97 million. It is projected to garner US$ 286.78 million by 2030 to expand at 6.2% CAGR during 2022–2030.
By end user, the Middle East & Africa coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held 60.2% share of Middle East & Africa coagulation market in 2022, amassing US$ 175.41 million. It is projected to garner US$ 285.61 million by 2030 to expand at 6.3% CAGR during 2022–2030.
Based on country, the Middle East & Africa coagulation market is categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Saudi Arabia held 34.6% share of Middle East & Africa coagulation market in 2022, amassing US$ 100.73 million. It is projected to garner US$ 164.34 million by 2030 to expand at 6.3% CAGR during 2022–2030.
Key players operating in the Middle East & Africa coagulation market are Siemens Healthineers AG; ImproGen Diagnostik Kimya San & Tic Ltd Åti; Sysmex Corp; F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Transasia Bio-Medicals Ltd; and Horiba Ltd, among others.
In Feb 2021, Siemens Healthineers and Sysmex Extend Hemostasis Agreement. Siemens Healthineers and Sysmex Corporation announced the renewal of the companies’ long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension. As part of the agreement Siemens Healthineers will distribute the new Sysmex CN Systems. In Aug 2021, Siemens Healthineers Launched Sysmex CN-3000 and CN-6000 Hemostasis Systems. This fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa coagulation market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the coagulation market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Coagulation Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Blood Disorders
4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis
5. Coagulation Market – Middle East & Africa Market Analysis
5.1 Middle East & Africa Coagulation Market Revenue (US$ million), 2022 – 2030
6. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by Disease Indication
6.1 Overview
6.2 Middle East & Africa Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
6.3.1 Overview
6.3.2 Vitamin K Deficiency: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
6.4.1 Overview
6.4.2 Liver Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
6.5.1 Overview
6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
6.6.1 Overview
6.6.2 Development of Circulating Anticoagulant: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
6.7.1 Overview
6.7.2 Hemophilia: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand’s Disease
6.8.1 Overview
6.8.2 Von Willebrand’s Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Others
6.9.1 Overview
6.9.2 Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Middle East & Africa Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
7.3.1 Overview
7.3.2 Clinical Laboratory Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
7.4.1 Overview
7.4.2 Point-of-Care Testing Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle east & Africa Coagulation Market – Revenue and Forecast to 2030 – by Offering
8.1 Overview
8.2 Middle East & Africa Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
8.3.1 Overview
8.3.2 Diagnosis: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Middle East & Africa Coagulation Market, by Diagnosis
8.4 Treatment
8.4.1 Overview
8.4.2 Treatment: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Middle East & Africa Coagulation Market, by Treatment
9. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by Technology
9.1 Overview
9.2 Middle East & Africa Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
9.3.1 Overview
9.3.2 Optical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
9.4.1 Overview
9.4.2 Mechanical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
9.5.1 Overview
9.5.2 Electrochemical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Middle East & Africa Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
10.3.1 Overview
10.3.2 Clinical Laboratories: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
10.4.1 Overview
10.4.2 Hospitals: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Coagulation Market – Country Analysis
11.1 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
11.1.1.1 Middle East & Africa Coagulation Market by Country
11.1.1.2 Saudi Arabia
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.2.3 Saudi Arabia Coagulation Market, by Disease Indication
11.1.1.2.4 Saudi Arabia Coagulation Market, by Type
11.1.1.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.2.5 Saudi Arabia Coagulation Market, by Offering
11.1.1.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
11.1.1.2.5.2 Saudi Arabia Coagulation Market, by Treatment
11.1.1.2.6 Saudi Arabia Coagulation Market, by Technology
11.1.1.2.7 Saudi Arabia Coagulation Market, by End User
11.1.1.3 South Africa
11.1.1.3.1 Overview
11.1.1.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.3.3 South Africa Coagulation Market, by Disease Indication
11.1.1.3.4 South Africa Coagulation Market, by Type
11.1.1.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.3.5 South Africa Coagulation Market, by Offering
11.1.1.3.5.1 South Africa Coagulation Market, by Diagnosis
11.1.1.3.5.2 South Africa Coagulation Market, by Treatment
11.1.1.3.6 South Africa Coagulation Market, by Technology
11.1.1.3.7 South Africa Coagulation Market, by End User
11.1.1.4 UAE
11.1.1.4.1 Overview
11.1.1.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.4.3 UAE Coagulation Market, by Disease Indication
11.1.1.4.4 UAE Coagulation Market, by Type
11.1.1.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.4.5 UAE Coagulation Market, by Offering
11.1.1.4.5.1 UAE Coagulation Market, by Diagnosis
11.1.1.4.5.2 UAE Coagulation Market, by Treatment
11.1.1.4.6 UAE Coagulation Market, by Technology
11.1.1.4.7 UAE Coagulation Market, by End User
11.1.1.5 Rest of Middle East & Africa
11.1.1.5.1 Overview
11.1.1.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
11.1.1.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
11.1.1.5.4 Rest of Middle East & Africa Coagulation Market, by Type
11.1.1.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
11.1.1.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
11.1.1.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
11.1.1.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
11.1.1.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
11.1.1.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12. Coagulation Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Siemens Healthineers AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Şti.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sysmex Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Genrui Biotech Co., Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Transasia Bio-Medicals Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Horiba Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Coagulation Market Segmentation
Table 2. Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 3. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 4. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 8. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 9. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 10. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 11. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 12. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 13. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 14. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 15. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 16. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 17. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 18. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 19. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 20. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 21. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 22. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 23. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 24. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 25. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 26. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 27. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 28. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 29. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 30. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 31. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 32. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 33. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 34. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 35. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 36. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 37. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 38. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 39. Recent Inorganic Growth Strategies in the Coagulation Market
Table 40. Recent Organic Growth Strategies in the Coagulation Market
Table 41. Glossary of Terms, Coagulation Market
LIST OF FIGURES
Figure 1. Middle East & Africa Coagulation Market Segmentation, By Country
Figure 2. Middle East & Africa Coagulation Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Coagulation Market Revenue (US$ million), 2020 – 2030
Figure 5. Middle East & Africa Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand’s Disease: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Middle East & Africa Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Middle East & Africa Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Middle East & Africa Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Coagulation Market, By Country (2022) (US$ million)
Figure 29. Middle East & Africa Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 34. Growth Strategies in the Coagulation Market
The List of Companies – Middle East & Africa Coagulation Market
1. F. Hoffmann-La Roche Ltd
2. Genrui Biotech Co Ltd
3. Horiba Ltd.
4. ImproGen Diagnostik Kimya San & Tic Ltd.Şti.
5. Siemens Healthineers AG
6. Sysmex Corp
7. Transasia Bio-Medicals Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.